{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "12929425", "DateCompleted": {"Year": "2004", "Month": "01", "Day": "14"}, "DateRevised": {"Year": "2019", "Month": "11", "Day": "07"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "1477-0520", "JournalIssue": {"Volume": "1", "Issue": "2", "PubDate": {"Year": "2003", "Month": "Jan", "Day": "21"}}, "Title": "Organic & biomolecular chemistry", "ISOAbbreviation": "Org Biomol Chem"}, "ArticleTitle": "Total synthesis of (+/-)-rhazinal, an alkaloidal spindle toxin from Kopsia teoi.", "Pagination": {"StartPage": "296", "EndPage": "305", "MedlinePgn": "296-305"}, "Abstract": {"AbstractText": ["The title alkaloid 1 and its B-nor-congener 3, both of which display potent and unusual anti-mitotic properties, have been synthesized in racemic form and characterised by single-crystal X-ray analysis."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Research School of Chemistry, Institute of Advanced Studies, Australian National University, Canberra, ACT 0200, Australia. mgb@rsc.anu.edu.au"}], "Identifier": [], "LastName": "Banwell", "ForeName": "Martin G", "Initials": "MG"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Edwards", "ForeName": "Alison J", "Initials": "AJ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Jolliffe", "ForeName": "Katrina A", "Initials": "KA"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Smith", "ForeName": "Jason A", "Initials": "JA"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Hamel", "ForeName": "Ernest", "Initials": "E"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Verdier-Pinard", "ForeName": "Pascal", "Initials": "P"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Org Biomol Chem", "NlmUniqueID": "101154995", "ISSNLinking": "1477-0520"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Aldehydes"}, {"RegistryNumber": "0", "NameOfSubstance": "Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Indolizines"}, {"RegistryNumber": "0", "NameOfSubstance": "Tubulin"}, {"RegistryNumber": "0", "NameOfSubstance": "rhazinal"}, {"RegistryNumber": "5V9KLZ54CY", "NameOfSubstance": "Vinblastine"}, {"RegistryNumber": "P88XT4IS4D", "NameOfSubstance": "Paclitaxel"}], "MeshHeadingList": [{"QualifierName": ["chemical synthesis", "pharmacology"], "DescriptorName": "Aldehydes"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Alkaloids"}, {"QualifierName": ["chemical synthesis", "pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": [], "DescriptorName": "Crystallography, X-Ray"}, {"QualifierName": ["drug effects"], "DescriptorName": "G2 Phase"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemical synthesis", "pharmacology"], "DescriptorName": "Indolizines"}, {"QualifierName": [], "DescriptorName": "Models, Molecular"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Paclitaxel"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Stereoisomerism"}, {"QualifierName": ["chemistry", "drug effects"], "DescriptorName": "Tubulin"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Vinblastine"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2003", "Month": "8", "Day": "22", "Hour": "5", "Minute": "0"}, {"Year": "2004", "Month": "1", "Day": "15", "Hour": "5", "Minute": "0"}, {"Year": "2003", "Month": "8", "Day": "22", "Hour": "5", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["12929425", "10.1039/b209992f"]}}], "PubmedBookArticle": []}